Journal of Thrombosis and Thrombolysis

, Volume 31, Issue 3, pp 265–274 | Cite as

Transforming oral anticoagulation by combining international normalized ratio (INR) self testing and online automated management

Article

Abstract

Because of the number and complexity of issues addressed, this manuscript is divided into two major sections. The first section focuses on how new technology can transform vitamin K antagonist therapy. Specifically, evidence suggest that combining INR self testing with online automated management (STOAM) can greatly reduce the time, expense, and hassle of managing VKA therapy; improve the quality of INR control to a degree that, in large studies, has been associated with a 50% or more reduction in major events (such as stroke, myocardial infarction, major hemorrhage, and death); reduce health care costs by an estimated $4 million per 1,000 patients per year; and improve quality of life and patient satisfaction. Such improved VKA therapy should be safer, more effective, and more cost-effective than the new oral anticoagulants. The improved efficiency and outcomes also should prompt reconsideration of indications in which VKA therapy may not be the current standard of care. Although new reimbursement models are clearly needed for STOAM, the current Medicare reimbursement model for patient self testing can be utilized to make VKA management financially viable and sustainable. The second section of this article focuses on additional considerations that may be important in optimizing VKA therapy and/or selecting an online management system. A brief review is provided to examine why a recent meta analysis and a large randomized trial of self testing did not find the same degree of improvement as reported in the four STOAM trials described in the first section of this article.

Keywords

Vitamin K antagonist Warfarin Oral anticoagulation International normalized ratio Information technology Self testing Anticoagulation management 

Notes

Potential conflicts of interest

Consultant to Genesis Advanced Technologies, Inc. in development of the ClotFree system, Research support from Roche Diagnostics, Inc., Advisory board member for Boehringer-Ingelheim and Daiichi-Sankyo, minor share holder of Alere, Inc.

References

  1. 1.
    Ryan F, Byrne S, O’Shea S (2009) Randomized controlled trial of supervised patient self-testing of warfarin therapy using an Internet-based expert system. J Thromb Haemost 7:1284–1290PubMedCrossRefGoogle Scholar
  2. 2.
    Harper PL, Pollock D (2008) Anticoagulation self-management using near patient testing and decision support software provided via an internet website improved anticoagulation control in patients on long-term warfarin. Blood (ASH Annual Meeting Abstracts 2008) 112:Abstract #1278Google Scholar
  3. 3.
    Ferrando F, Mira Y, Contreras MT, Aguado C, Aznar JA (2010) Implementation of SintromacWebtm, a new internet-based tool for oral anticoagulation therapy telecontrol: study on system consistency and patient satisfaction. Thromb Haemost 103:1091–1101PubMedGoogle Scholar
  4. 4.
    Bussey HI, Walker MB, Bussey-Smith KL, Frei CR (2010) Superior oral anticoagulation management with self testing and automated online management; An interim analysis. In: American heart association meeting on quality of care and outcomes research in cardiovascular disease and stroke 2010 meeting, poster # P260 ID#341, Washington, 21 May 2010Google Scholar
  5. 5.
    Forcade NA, Frei CR, Walker MB, Bussey-Smith KL, Daniels KR, Bussey HI (2010) INR self-testing in warfarin anticoagulation improves patient satisfaction and clinical efficiency while reducing patient costs. In: American college of clinical pharmacy meeting, poster #113E, Austin, 19 Oct 2010Google Scholar
  6. 6.
    Matcher DB, Jacobson A, Dolor R et al (2010) Effect of home testing of international normalized ratio on clinical events. N Engl J Med 363:1608–1620CrossRefGoogle Scholar
  7. 7.
    Poller L, Keown M, Ibrahim S, For the European Action on Anticoagulation (EAA) et al (2009) A multicentre randomized assessment of the DAWN AC computer-assisted oral anticoagulant dosing program. Thromb Haemost 101:487–494PubMedGoogle Scholar
  8. 8.
    White HD, Gruber M, Feyzi J, Kaatz S et al (2007) Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 167:239–245PubMedCrossRefGoogle Scholar
  9. 9.
    Connolly SJ, Ezekowitz MD, Yusuf S, RE-LY Steering Committee Investigators et al (2009) Dabigatran vs warfarin in patients with atrial fibrillation. N Engl J Med 361:113–151CrossRefGoogle Scholar
  10. 10.
    Gage BF (2009) Can we rely on RE-LY? N Engl J Med 361:1200–1202PubMedCrossRefGoogle Scholar
  11. 11.
    Wallentin L (2010) http://www.theheart.org/article/1046957.do. Accessed last on 28 Dec 2010
  12. 12.
    Cannegieter SC, Rosendaal FR, Wintzen AR et al (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 333:11–17PubMedCrossRefGoogle Scholar
  13. 13.
    Veeger NJGM, Piersma-Wichers M, Hillege HL, Cruns HJGM, van der Meer J (2006) Early detection of patients with a poor response to vitamin K antagonists: the clinical impact of individual time within target range in patients with heart disease. J Thromb Haemost 4:1625–1627PubMedCrossRefGoogle Scholar
  14. 14.
    Chimowitz MI, Lynn MJ, Howlett-Smith H et al (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305–1316PubMedCrossRefGoogle Scholar
  15. 15.
    Koroshetz WJ (2005) Warfarin, aspirin, and intracranial vascular disease. N Engl J Med 352:1368–1370PubMedCrossRefGoogle Scholar
  16. 16.
    Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133:454s–545sPubMedCrossRefGoogle Scholar
  17. 17.
    Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR (2005) Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med 143:241–250PubMedGoogle Scholar
  18. 18.
    Van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE (2002) Aspirin and coumadin after acute coronary syndrome (the ASPECT-2 study): a randomized controlled trial. Lancet 360:109–113PubMedCrossRefGoogle Scholar
  19. 19.
  20. 20.
    Rospond RM, Quandt CM, Clark GM, Bussey HI (1989) Evaluation of factors associated with stability of anticoagulation therapy. Pharmacotherapy 9:207–213PubMedGoogle Scholar
  21. 21.
    Thoma BN, Barron L, Andrson MM, Walker MB, Bussey HI (2007) The feasibility and potential value of automated online anticoagulation monitoring of warfarin-treated patients. In: Am Coll Clin Pharm meeting 2007 (Abstract #336)Google Scholar
  22. 22.
    Witt DM, Delate T, Clark NP, on behalf of the Warfarin Associated Research Projects, other EnDeavors (WARPED) Consortium et al (2009) Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood 114:952–956PubMedCrossRefGoogle Scholar
  23. 23.
    Witt DM, Delate T, Clark NP, on behalf of the WARPED Consortium et al (2010) Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. J Thromb Haemost 8:744–749PubMedCrossRefGoogle Scholar
  24. 24.
  25. 25.
  26. 26.
  27. 27.
    Bussey HI (2010) The financial viability of an anticoagulation clinic: a discussion from the anticoagulation forum meeting, May 2009. J Thromb Thrombolysis 29:227–232PubMedCrossRefGoogle Scholar
  28. 28.
    Askey JM, Cherry CB (1950) Thromboembolism associated with auricular fibrillation; continuous anticoagulant therapy. JAMA 144:97–100Google Scholar
  29. 29.
    Bussey HI, Chiquette E, Bianco TM et al (1997) A statistical and clinical evaluation of fingerstick and routine laboratory prothrombin time measurements. Pharmacotherapy 17:861–866PubMedGoogle Scholar
  30. 30.
    Kagansky N, Knobler H, Rimon E, Zinaida O, Levy S (2004) Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med 164:2044–2050PubMedCrossRefGoogle Scholar
  31. 31.
    Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, Heneghan CJ (2010) Self monitoring and self management of oral anticoagulation. Cochrane Database Syst Rev 2010, 4: Art. No. CD003839. doi: 10.1002/14651858.CD003839.pub2

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.College of PharmacyThe University of Texas at Austin and the University of Texas Health Science Center at San AntonioSan AntonioUSA
  2. 2.Genesis Clinical ResearchSan AntonioUSA
  3. 3.ClotCare.orgSan AntonioUSA

Personalised recommendations